Elunonavir
Elunonavir (GS-1156) is a HIV protease inhibitor with a high barrier to resistance and excellent metabolic stability. Elunonavir is able to overcome rapid CYP-mediated metabolism, resulting in a significantly prolonged half-life and the potential to reduce dosing frequency without the need for pharmacokinetic enhancers[1].
Product Specifications
CAS Number
[2242428-57-3]
UNSPSC
12352005
Target
HIV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/elunonavir.html
Smiles
O=C(N[C@@H](CC1=CC=C(C#CC2=CN=C(N=C2)N3CC4CCC(C3)N4C5COC5)C=C1)[C@H](CN(CC(C(F)=C6)=C(F)C=C6C7=NN(C(F)F)C=C7)NC([C@@H](NC(OC)=O)C(C)(C(F)(F)F)C)=O)O)[C@@H](NC(OC)=O)C(C)(C(F)(F)F)C
Molecular Formula
C52H59F10N11O8
Molecular Weight
1156.08
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
